Key points are not available for this paper at this time.
Design
Review
Does not warrant changes to CAD hypertension care; leaves open mechanism-specific therapeutic targets for trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Narkiewicz et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: